Encompass Health (NYSE: EHC) credits 85 RSUs to non-employee director

Q: What insider transaction did Encompass Health (EHC) report for Leslye G. Katz?

Encompass Health reported that non-employee director Leslye G. Katz received an award of 85 RSUs tied to common stock. The grant was a non-cash acquisition of restricted stock units credited as dividend equivalents on July 15, 2026.

Q: How many RSUs were awarded and at what price in Encompass Health (EHC)'s latest Form 4?

Leslye G. Katz was awarded 85 restricted stock units (RSUs) at an effective price of $0.00 per unit . This reflects a compensation-related equity credit, not an open-market purchase or sale of Encompass Health common stock.

Q: Why were additional RSUs credited to Encompass Health (EHC) directors' accounts?

Additional RSUs were credited under existing restricted stock unit award agreements in connection with common stock dividend payments. The number of RSUs is based on RSUs held on the dividend record date, the $0.19 per share dividend, and the $109.88 closing price.

Q: What dividend and stock price triggered the RSU credit at Encompass Health (EHC)?

On July 15, 2026 , Encompass Health paid a common stock dividend of $0.19 per share , and the stock’s closing price was $109.88 . These figures were used to calculate the 85 RSUs credited to director Leslye G. Katz.

Q: What is Leslye G. Katz’s total direct holding after this Encompass Health (EHC) transaction?

After the award of 85 RSUs , Leslye G. Katz’s direct holdings total 49,643 shares/units of Encompass Health equity. This reflects her position immediately following the July 15, 2026, dividend-related RSU credit.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Encompass Health Corp reported that non-employee director Leslye G. Katz acquired 85 Encompass Health Common Stock-equivalent RSUs at $0.00 per unit under a grant/award transaction. These RSUs were credited as dividend equivalents tied to a $0.19 per share common stock dividend, using a $109.88 closing price on July 15, 2026. Following this award, Katz’s direct holdings total 49,643 shares/units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KATZ LESLYE G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	85	$0.00	--

Holdings After Transaction: Encompass Health Common Stock — 49,643 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

RSUs Awarded: 85 RSUs Award Price per Unit: $0.00 Holdings After Transaction: 49,643 shares/units +2 more

5 metrics

RSUs Awarded 85 RSUs Grant/award acquisition to Leslye G. Katz on July 15, 2026

Award Price per Unit $0.00 Grant of RSUs credited without cash consideration

Holdings After Transaction 49,643 shares/units Total direct holdings of Leslye G. Katz following RSU award

Dividend per Share $0.19 per share Common stock dividend paid on July 15, 2026, used to calculate RSUs

Closing Price on Dividend Date $109.88 Encompass Health common stock closing price on July 15, 2026

Key Terms

restricted stock unit award agreements, RSUs, dividend record date, closing price

4 terms

restricted stock unit award agreements financial

"Pursuant to outstanding restricted stock unit award agreements, additional RSUs are credited"

RSUs financial

"additional restricted stock units ("RSUs") are credited to each non-employee director's account"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

dividend record date financial

"number of the RSUs in each director's account on the associated dividend record date"

closing price financial

"divided by (b) the closing price on the dividend payment date"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/16/2026 - 04:13 PM Accepted by SEC EDGAR 07/16/2026 - 04:13 PM

FAQ

What insider transaction did Encompass Health (EHC) report for Leslye G. Katz?

Encompass Health reported that non-employee director Leslye G. Katz received an award of 85 RSUs tied to common stock. The grant was a non-cash acquisition of restricted stock units credited as dividend equivalents on July 15, 2026.

How many RSUs were awarded and at what price in Encompass Health (EHC)'s latest Form 4?

Leslye G. Katz was awarded 85 restricted stock units (RSUs) at an effective price of $0.00 per unit. This reflects a compensation-related equity credit, not an open-market purchase or sale of Encompass Health common stock.

Why were additional RSUs credited to Encompass Health (EHC) directors' accounts?

Additional RSUs were credited under existing restricted stock unit award agreements in connection with common stock dividend payments. The number of RSUs is based on RSUs held on the dividend record date, the $0.19 per share dividend, and the $109.88 closing price.

What dividend and stock price triggered the RSU credit at Encompass Health (EHC)?

On July 15, 2026, Encompass Health paid a common stock dividend of $0.19 per share, and the stock’s closing price was $109.88. These figures were used to calculate the 85 RSUs credited to director Leslye G. Katz.

What is Leslye G. Katz’s total direct holding after this Encompass Health (EHC) transaction?

After the award of 85 RSUs, Leslye G. Katz’s direct holdings total 49,643 shares/units of Encompass Health equity. This reflects her position immediately following the July 15, 2026, dividend-related RSU credit.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KATZ LESLYE G

(Last)

(First)

(Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM

ALABAMA

35242

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Encompass Health Common Stock	07/15/2026		A		85⁽¹⁾	A	$0	49,643	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Leslye G. Katz	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR